NO20065022L - Substituerte 4-alkyl- og 4-alkanoyl-piperidinderivater og deres anvendelse som neurokininantagonister - Google Patents
Substituerte 4-alkyl- og 4-alkanoyl-piperidinderivater og deres anvendelse som neurokininantagonisterInfo
- Publication number
- NO20065022L NO20065022L NO20065022A NO20065022A NO20065022L NO 20065022 L NO20065022 L NO 20065022L NO 20065022 A NO20065022 A NO 20065022A NO 20065022 A NO20065022 A NO 20065022A NO 20065022 L NO20065022 L NO 20065022L
- Authority
- NO
- Norway
- Prior art keywords
- antagonistic activity
- alkanoyl
- substituted
- alkyl
- piperidine derivatives
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/12—Antidiuretics, e.g. drugs for diabetes insipidus
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Pulmonology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Pain & Pain Management (AREA)
- Hospice & Palliative Care (AREA)
- Otolaryngology (AREA)
- Psychiatry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
Abstract
Oppfinnelsen vedrører substituerte 4-alkyl- og 4-alkanoyl-piperidinderivater som har neurokininantagonistisk aktivitet, spesielt NKi-antagonistisk aktivitet og en kombinert NK1/NK3- antagonistisk aktivitet, sammensetninger omfattende dem og deres anvendelse som en medisin, spesielt for behandlingen og/eller profylaksen av schizofreni, emese, angst og depresjon, irritabelt tarmsyndrom (IBS), sirkadianske rytmeforstyrrelser, preeklampsi, nocisepsjon, smerte, spesielt visceral og nevropatisk smerte, pankreatitt, nevrogen inflammasjon, astma, kronisk obstruktiv lungesykdom (KOL) og urineringslidelser slik som urininkontinens. Forbindelsene ifølge oppfinnelsen kan representeres ved generell formel (I) og omfatter også de farmasøytisk akseptable syre- eller baseaddisjonssalter derav, de stereokjemisk isomere former derav, iV-oksidformen derav og prodroger derav, hvori alle substituenter er definert som i krav 1.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP04101467 | 2004-04-08 | ||
PCT/EP2005/051509 WO2005097774A1 (en) | 2004-04-08 | 2005-04-04 | Substituted 4-alkyl- and 4-alkanoyl-piperidine derivatives and their use as neurokinin antagonists |
Publications (1)
Publication Number | Publication Date |
---|---|
NO20065022L true NO20065022L (no) | 2006-11-03 |
Family
ID=34928945
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20065022A NO20065022L (no) | 2004-04-08 | 2006-11-03 | Substituerte 4-alkyl- og 4-alkanoyl-piperidinderivater og deres anvendelse som neurokininantagonister |
Country Status (23)
Country | Link |
---|---|
US (1) | US20070213346A1 (no) |
EP (1) | EP1737838B1 (no) |
JP (1) | JP2007532516A (no) |
KR (1) | KR20070007347A (no) |
CN (1) | CN1938291B (no) |
AR (1) | AR048532A1 (no) |
AT (1) | ATE396185T1 (no) |
AU (1) | AU2005231986B2 (no) |
BR (1) | BRPI0509720A (no) |
CA (1) | CA2561967A1 (no) |
DE (1) | DE602005007002D1 (no) |
EA (1) | EA010312B1 (no) |
ES (1) | ES2307169T3 (no) |
IL (1) | IL178461A0 (no) |
JO (1) | JO2525B1 (no) |
MX (1) | MXPA06011683A (no) |
MY (1) | MY142773A (no) |
NO (1) | NO20065022L (no) |
NZ (1) | NZ550098A (no) |
PA (1) | PA8628901A1 (no) |
TW (1) | TWI358298B (no) |
WO (1) | WO2005097774A1 (no) |
ZA (1) | ZA200608356B (no) |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
BRPI0609251A2 (pt) * | 2005-02-23 | 2010-03-09 | Schering Corp | derivados de piperidinil piperazina úteis como inibidores de receptores de quimiocinas |
TWI385169B (zh) | 2005-10-31 | 2013-02-11 | Eisai R&D Man Co Ltd | 經雜環取代之吡啶衍生物及含有彼之抗真菌劑 |
TW200841879A (en) | 2007-04-27 | 2008-11-01 | Eisai R&D Man Co Ltd | Pyridine derivatives substituted by heterocyclic ring and phosphonoamino group, and anti-fungal agent containing same |
US8513287B2 (en) | 2007-12-27 | 2013-08-20 | Eisai R&D Management Co., Ltd. | Heterocyclic ring and phosphonoxymethyl group substituted pyridine derivatives and antifungal agent containing same |
KR20120027177A (ko) * | 2009-04-02 | 2012-03-21 | 메르크 파텐트 게엠베하 | 오토탁신 저해제로서의 피페리딘 및 피라진 유도체 |
CN102428069B (zh) | 2009-04-02 | 2014-04-02 | 盐野义制药株式会社 | 丙烯酰胺化合物及其用途 |
JP5806672B2 (ja) * | 2009-10-30 | 2015-11-10 | ドメイン・セラピューティクス | 新規オキシム誘導体及び代謝型グルタミン酸受容体のアロステリック調節因子としての利用 |
RU2673489C2 (ru) * | 2013-09-12 | 2018-11-27 | Ф. Хоффманн-Ля Рош Аг | Производные индолкарбоксамида |
WO2016184829A1 (en) * | 2015-05-18 | 2016-11-24 | Nerre Therapeutics Limited | Dual nk-1/nk-3 receptor antagonists for the treatment of sex-hormone-dependent diseases |
EP3765024B1 (en) | 2018-03-14 | 2023-11-22 | KaNDy Therapeutics Limited | Novel pharmaceutical formulation comprising dual nk-1/nk-3 receptor antagonists. |
HUE063796T2 (hu) | 2019-06-12 | 2024-01-28 | Nouryon Chemicals Int Bv | Eljárás diacil-peroxidok elõállítására |
US20220306490A1 (en) * | 2019-06-12 | 2022-09-29 | Nouryon Chemicals International B.V. | Method for isolating carboxylic acid from an aqueous side stream |
BR112021024874A2 (pt) | 2019-06-12 | 2022-01-25 | Nouryon Chemicals Int Bv | Processo para a produção de peróxidos de diacila |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NZ321575A (en) * | 1995-10-30 | 1999-05-28 | Janssen Pharmaceutica Nv | 1-(1,2-disubstituted piperidinyl)-4- substituted piperazine derivatives |
TW382017B (en) * | 1995-12-27 | 2000-02-11 | Janssen Pharmaceutica Nv | 1-(1,2-disubstituted piperidinyl)-4-(fused imidazole)-piperidine derivatives |
GB0025354D0 (en) * | 2000-10-17 | 2000-11-29 | Glaxo Group Ltd | Chemical compounds |
US6642226B2 (en) * | 2001-02-06 | 2003-11-04 | Hoffman-La Roche Inc. | Substituted phenyl-piperidine methanone compounds |
AU2003298369B2 (en) * | 2002-12-23 | 2009-08-27 | Janssen Pharmaceutica N.V. | Substituted 4-(4-piperidin-4-yl-piperazin-1-yl)-azepane derivatives and their use as neurokinin antagonists |
-
2005
- 2005-03-22 JO JO200534A patent/JO2525B1/en active
- 2005-04-04 EA EA200601880A patent/EA010312B1/ru not_active IP Right Cessation
- 2005-04-04 KR KR1020067021935A patent/KR20070007347A/ko not_active Application Discontinuation
- 2005-04-04 AT AT05729797T patent/ATE396185T1/de active
- 2005-04-04 MX MXPA06011683A patent/MXPA06011683A/es active IP Right Grant
- 2005-04-04 WO PCT/EP2005/051509 patent/WO2005097774A1/en active IP Right Grant
- 2005-04-04 CA CA002561967A patent/CA2561967A1/en not_active Abandoned
- 2005-04-04 NZ NZ550098A patent/NZ550098A/en unknown
- 2005-04-04 EP EP05729797A patent/EP1737838B1/en active Active
- 2005-04-04 ES ES05729797T patent/ES2307169T3/es active Active
- 2005-04-04 BR BRPI0509720-7A patent/BRPI0509720A/pt not_active IP Right Cessation
- 2005-04-04 CN CN2005800108231A patent/CN1938291B/zh not_active Expired - Fee Related
- 2005-04-04 JP JP2007506775A patent/JP2007532516A/ja not_active Ceased
- 2005-04-04 AU AU2005231986A patent/AU2005231986B2/en not_active Ceased
- 2005-04-04 DE DE602005007002T patent/DE602005007002D1/de active Active
- 2005-04-04 US US11/547,868 patent/US20070213346A1/en not_active Abandoned
- 2005-04-05 PA PA20058628901A patent/PA8628901A1/es unknown
- 2005-04-06 MY MYPI20051549A patent/MY142773A/en unknown
- 2005-04-07 TW TW094110941A patent/TWI358298B/zh not_active IP Right Cessation
- 2005-04-07 AR ARP050101376A patent/AR048532A1/es not_active Application Discontinuation
-
2006
- 2006-10-05 IL IL178461A patent/IL178461A0/en unknown
- 2006-10-06 ZA ZA200608356A patent/ZA200608356B/en unknown
- 2006-11-03 NO NO20065022A patent/NO20065022L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
DE602005007002D1 (de) | 2008-07-03 |
NZ550098A (en) | 2009-10-30 |
KR20070007347A (ko) | 2007-01-15 |
BRPI0509720A (pt) | 2007-09-25 |
TW200603797A (en) | 2006-02-01 |
JO2525B1 (en) | 2010-03-17 |
ATE396185T1 (de) | 2008-06-15 |
AR048532A1 (es) | 2006-05-03 |
MY142773A (en) | 2010-12-31 |
ES2307169T3 (es) | 2008-11-16 |
EA200601880A1 (ru) | 2007-02-27 |
CN1938291A (zh) | 2007-03-28 |
AU2005231986A1 (en) | 2005-10-20 |
EP1737838B1 (en) | 2008-05-21 |
IL178461A0 (en) | 2007-02-11 |
ZA200608356B (en) | 2008-07-30 |
JP2007532516A (ja) | 2007-11-15 |
MXPA06011683A (es) | 2006-12-14 |
TWI358298B (en) | 2012-02-21 |
CN1938291B (zh) | 2011-11-16 |
PA8628901A1 (es) | 2006-09-08 |
WO2005097774A1 (en) | 2005-10-20 |
EA010312B1 (ru) | 2008-08-29 |
CA2561967A1 (en) | 2005-10-20 |
AU2005231986B2 (en) | 2011-02-24 |
EP1737838A1 (en) | 2007-01-03 |
US20070213346A1 (en) | 2007-09-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20065022L (no) | Substituerte 4-alkyl- og 4-alkanoyl-piperidinderivater og deres anvendelse som neurokininantagonister | |
WO2006094934A8 (en) | Substituted oxa-diaza-spiro-[5.5]-undecanone derivatives and their use as neurokinin antagonists | |
NO20054878L (no) | 2-Fenoksy- og 2-fenylsulfonamidderivater med CCR3-antagonistisk aktivitet for behandling av astma og andre inflammasjons- eller immunologiske forstyrrelser | |
JO2676B1 (en) | Derivatives of second-aza-spiro- (5,4) -dikan and their use as antihistamines | |
JO2527B1 (en) | Derivatives of second-aza-Spiro- (5,5) -andecan and their use as antihistamines | |
NO20070076L (no) | Nye indazolkarboksamider og deres anvendelse | |
NO20082000L (no) | Pyrimidinamidforbindelser som PGDS-inhibitorer | |
WO2010018109A3 (en) | Substituted aminotetralines | |
NO20054206L (no) | Bifenylderivater | |
CL43596B (es) | Compuestos derivados de pirimidina; composicion farmaceutica; y su uso para tratar o prevenir un trastorno o enfermedad relacionado con la actividad de crth2, tales como asma, rinitis alergica, dermatitis, atopica y conjuntivitis alergica. | |
JP2017528507A5 (no) | ||
NO20063693L (no) | Forbindelse og metode for anvendelse | |
NO20074592L (no) | Acetylenyl-pyrazolo-pyrimidinderivater som mGluR2-antagonister | |
WO2008080844A9 (en) | Azaspiro derivatives | |
AR080746A1 (es) | (r)-n-(3-(7-metil-1h-indazol-5-il)1-(4-(1-metilpiperidin-4-il)piperazin-1-il)-1-oxopropan-2-il)-4-(2-oxo-1,2-dihidroquinolin-3-il)piperidina-1-carboxamida antagonista de receptores cgrp. | |
CO2021017031A2 (es) | Derivados de aminoquinazolina como inhibidores del purinoreceptor 3 de p2x (p2x3) | |
NZ591914A (en) | Naphthylacetic acids | |
NO20084603L (no) | Dialkylfenylforbindelser som har beta2 adrenergisk reseptoragonist- og muskarin reseptoragonistaktivitet | |
WO2006011024A3 (en) | New tricyclic compounds useful for the treatment of inflammatory and allergic disorders: process for their preparation and pharmaceutical compositions containing them | |
AR078552A1 (es) | Derivados de feniloxadiazol como agentes inhibidores de las pgds | |
MX2009005507A (es) | Derivados de espiro-piperidina. | |
RU2008148941A (ru) | 4-[(3-фторфенокси)фенилметил]пиперидин метансульфонат, применение, способ синтеза и фармацевтические композиции | |
NO20080457L (no) | Kjemiske forbindelser | |
EA200701898A1 (ru) | Производные диаза-спиро-[4.4]-нонана в качестве антагонистов нейрокинина (nk1) | |
MX2009005504A (es) | Derivados de espiro piperidina como antagonistas del receptor via. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |